Company Filing History:
1 out of 647 
1 out of 203 
1 out of 894 
Years Active: 2025
Title: The Innovative Contributions of Peter King
Introduction
Peter King is an accomplished inventor based in Birmingham, AL (US). He has made significant strides in the field of biomedical research, particularly in the development of compounds that target RNA-binding proteins. His work has the potential to impact therapeutic options for various diseases, including cancer and inflammation.
Latest Patents
Peter King holds a patent for "RNA-binding protein multimerization inhibitors and methods of use thereof." This patent describes compounds that inhibit RNA-binding proteins, such as Human antigen R protein (HuR). The compounds exhibit a high affinity for HuR multimers and are designed to inhibit pathological processes that promote cancer and inflammation. Notably, these compounds are highly water-soluble and demonstrate good biodistribution for both systemic and central nervous system disease processes. This innovation provides a unique therapeutic option for disease processes related to neoplastic progression or acute or chronic inflammation. He has 1 patent to his name.
Career Highlights
Throughout his career, Peter King has worked with notable organizations, including the UAB Research Foundation and Southern Research Institute. His contributions to these institutions have been instrumental in advancing research and development in the biomedical field.
Collaborations
Peter has collaborated with esteemed colleagues such as Louis B. Nabors and Natalia Filippova. Their combined expertise has further enriched the research landscape in which they operate.
Conclusion
Peter King's innovative work in developing RNA-binding protein inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in treating diseases related to cancer and inflammation.